Last10K.com

Ac Immune Sa (ACIU) SEC Filing 20-F Annual report for the fiscal year ending Sunday, December 31, 2017

Ac Immune Sa

HISTORY TOOLS
CIK: 1651625 Ticker: ACIU

View differences made from one year to another to evaluate Ac Immune Sa's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Ac Immune Sa.

Continue

Assess how Ac Immune Sa's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Ac Immune Sa's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 20-F Annual Report

Document And Entity Information
Balance Sheets
Statements Of Cash Flows
Statements Of Cash Flows (parenthetical)
Statements Of Changes In Equity
Statements Of Comprehensive Income / (loss)
Statements Of Comprehensive Income / (loss) (parenthetical)
Statements Of Income / (loss)
Basis Of Preparation
Basis Of Preparation (details)
Capital Risk Management
Cash And Cash Equivalents
Cash And Cash Equivalents (details)
Cash And Cash Equivalents (tables)
Commitments And Contingencies
Commitments And Contingencies (details)
Commitments And Contingencies (tables)
Deferred Income
Deferred Income (details)
Earnings Per Share
Earnings Per Share (details)
Earnings Per Share (tables)
Expenses By Category
Expenses By Category (details)
Expenses By Category (tables)
Financial Assets
Financial Assets (details)
Financial Instruments And Risk Management
Financial Instruments And Risk Management (details)
Financial Instruments And Risk Management (tables)
General Information
General Information (details)
Income Taxes
Income Taxes (details)
Income Taxes (tables)
Income Taxes, Unrecognized Deductible Temporary Differences, Unused Tax Losses And Unused Tax Credits (details)
Long Term Financing Obligation
Long Term Financing Obligation (details)
Other Current Receivables
Other Current Receivables (details)
Other Current Receivables (tables)
Post Balance Sheet Events
Post Balance Sheet Events (details)
Prepaid Expenses And Accrued Income
Prepaid Expenses And Accrued Income (details)
Prepaid Expenses And Accrued Income (tables)
Property, Plant And Equipment
Property, Plant And Equipment (details)
Property, Plant And Equipment (tables)
Related-party Transactions
Related-party Transactions (details)
Related-party Transactions (tables)
Retirement Benefit Plan
Retirement Benefit Plan (details)
Retirement Benefit Plan (tables)
Retirement Benefit Plan, Actuarial Assumptions And Sensitivity Analysis (details)
Retirement Benefit Plan, Change In Net Definied Benefit Liability (details)
Retirement Benefit Plan, Changes In Defined Benefit Obligation (details)
Retirement Benefit Plan, Changes In Fair Value Of Plan Assets (details)
Revenues
Revenues (details)
Revenues (tables)
Share Capital
Share Capital (details)
Share Capital (tables)
Share-based Compensation
Share-based Compensation (tables)
Share-based Compensation, Non-vested Share Awards (details)
Share-based Compensation, Plans Outstanding (details)
Share-based Compensation, Summary Information (details)
Share-based Compensation, Weighted Average Exercise Prices (details)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (policies)
Summary Of Significant Accounting Policies (tables)
Summary Of Significant Accounting Policies, Income Taxes And Segment Reporting (details)
Summary Of Significant Accounting Policies, Property, Plant And Equipment (details)
Summary Of Significant Accounting Policies, Share Capital And Initial Public Offering (details)
Summary Of Significant Accounting Policies, Share Capital And Initial Public Offering, Preferred Shares (details)
Trade Payables And Accrued Liabilities
Trade Payables And Accrued Liabilities (details)
Trade Payables And Accrued Liabilities (tables)
Ticker: ACIU
CIK: 1651625
Form Type: 20-F Annual Report
Accession Number: 0000950103-18-003508
Submitted to the SEC: Tue Mar 20 2018 6:03:27 AM EST
Accepted by the SEC: Tue Mar 20 2018
Period: Sunday, December 31, 2017
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/aciu/0000950103-18-003508.htm